X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1743) 1743
Publication (155) 155
Book Review (91) 91
Book Chapter (22) 22
Magazine Article (19) 19
Newspaper Article (11) 11
Newsletter (5) 5
Conference Proceeding (3) 3
Dissertation (3) 3
Book / eBook (2) 2
Trade Publication Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1404) 1404
index medicus (934) 934
female (560) 560
male (517) 517
herpes zoster (445) 445
aged (437) 437
middle aged (411) 411
antiviral agents - therapeutic use (405) 405
vaccination (387) 387
herpes zoster - prevention & control (383) 383
shingles (382) 382
vaccines (372) 372
immunology (361) 361
adult (340) 340
herpes-zoster (319) 319
postherpetic neuralgia (297) 297
infections (280) 280
health aspects (269) 269
varicella (244) 244
viruses (244) 244
child (238) 238
epidemiology (238) 238
herpes zoster - epidemiology (238) 238
infectious diseases (232) 232
herpes zoster - drug therapy (225) 225
virus diseases (219) 219
risk factors (218) 218
immunization (212) 212
vaccine (212) 212
prevention (211) 211
medicine, research & experimental (210) 210
herpes viruses (197) 197
aged, 80 and over (191) 191
infection (190) 190
adolescent (187) 187
chickenpox (180) 180
chicken pox (178) 178
acyclovir - therapeutic use (171) 171
animals (171) 171
medicine, general & internal (166) 166
incidence (162) 162
chickenpox - prevention & control (160) 160
care and treatment (159) 159
pharmacology & pharmacy (158) 158
herpes zoster vaccine - therapeutic use (157) 157
herpesvirus 3, human - immunology (157) 157
research (154) 154
herpes-simplex-virus (151) 151
acyclovir (150) 150
herpes zoster - complications (148) 148
age (146) 146
child, preschool (146) 146
united-states (144) 144
children (138) 138
pain (138) 138
analysis (137) 137
double-blind (131) 131
treatment outcome (131) 131
herpes zoster - immunology (130) 130
herpes zoster - diagnosis (127) 127
adults (124) 124
infant (123) 123
varicella-zoster virus (121) 121
medicine & public health (120) 120
virology (120) 120
herpes simplex (118) 118
safety (115) 115
antiviral agents (114) 114
drug therapy (114) 114
studies (113) 113
allergy and immunology (112) 112
dermatology (112) 112
disease (111) 111
herpes simplex virus (111) 111
virus (110) 110
internal medicine (104) 104
young adult (103) 103
microbiology (101) 101
article (100) 100
medical research (100) 100
neuralgia, postherpetic - prevention & control (100) 100
population (100) 100
diagnosis (99) 99
review (98) 98
immunocompromised host (96) 96
public health (95) 95
risk-factors (95) 95
mortality (91) 91
chickenpox - epidemiology (90) 90
patients (90) 90
risk (90) 90
varicella zoster virus (90) 90
varicella-zoster-virus (90) 90
chickenpox vaccine - therapeutic use (89) 89
neuralgia (89) 89
retrospective studies (89) 89
pediatrics (87) 87
abridged index medicus (86) 86
herpes zoster vaccine - administration & dosage (86) 86
influenza (84) 84
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1742) 1742
French (21) 21
German (19) 19
Russian (5) 5
Japanese (4) 4
Spanish (4) 4
Finnish (2) 2
Czech (1) 1
Danish (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs & Aging, ISSN 1170-229X, 02/2010, Volume 27, Issue 2, pp. 159 - 176
Individuals who have been infected with varicella zoster virus (VZV) are at risk for developing herpes zoster and this risk appears to be related to a decline... 
Herpes-zoster, prevention | Adis-Drug-Evaluations | Varicella-zoster-virus-vaccine-live, pharmacodynam | Varicella-zoster-virus-vaccine-live, pharmacokinet | Postherpetic-neuralgia, prevention | Varicella-zoster-virus-vaccine-live, therapeutic u | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Varicella-zoster-virus-vaccine-live, pharmacokinetics | Herpes-zoster, Prevention | Varicella-zoster-virus-vaccine-live, pharmacodynamics | Varicella-zoster-virus- vaccine-live, therapeutic use | COST-EFFECTIVENESS | IMMUNOGENICITY | MANAGEMENT | SAFETY | IMMUNE-RESPONSES | PHARMACOLOGY & PHARMACY | GERIATRICS & GERONTOLOGY | Herpes Zoster - prevention & control | Age Factors | Humans | Vaccination | Cost of Illness | Herpesvirus 3, Human - immunology | Vaccines, Attenuated - economics | Incidence | Neuralgia, Postherpetic - prevention & control | Neuralgia, Postherpetic - immunology | Vaccines, Attenuated - administration & dosage | Neuralgia, Postherpetic - epidemiology | Adult | Herpes Zoster - epidemiology | Chickenpox Vaccine - economics | Cost-Benefit Analysis - economics | Herpes Zoster - immunology | Risk Factors | Immunocompetence - immunology | Treatment Outcome | Chickenpox Vaccine - administration & dosage | Health Services for the Aged | Herpes Zoster Vaccine - economics | Herpes Zoster Vaccine - administration & dosage | Randomized Controlled Trials as Topic | Immunity, Cellular - immunology | Antibodies, Viral - immunology | Immunologic Memory | Prevention | Complications and side effects | Shingles (Disease) | Herpesvirus vaccines | Aged | Dosage and administration | Research | Neuralgia | Health aspects | Risk factors
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2008, Volume 197, Issue 6, pp. 825 - 835
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2013, Volume 56, Issue 8, pp. 1085 - 1093
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1766 - 1766
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1765 - 1767
To the Editor: In his review article on herpes zoster, Cohen (July 18 issue) 1 reports that the live attenuated herpes zoster vaccine can be given to persons... 
MEDICINE, GENERAL & INTERNAL | VACCINE | Male | Antiviral Agents - therapeutic use | Humans | Herpes Zoster | Herpes Zoster Vaccine | Herpes zoster | Vaccines | Geriatrics
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 12, pp. 2122 - 2125
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 15, pp. 1745 - 1753
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1765 - 1766
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2017, Volume 69, Issue 10, pp. 1969 - 1977
Objective Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster, and vaccination is recommended for patients ages 50 years and older,... 
RESPONSES | MODIFYING ANTIRHEUMATIC DRUGS | EFFICACY | HERPES-ZOSTER | AMERICAN-COLLEGE | METHOTREXATE | RHEUMATOLOGY | COMBINATION | RECIPIENTS | CP-690,550 | Herpes Zoster - prevention & control | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Humans | Middle Aged | Herpesvirus 3, Human - immunology | Male | Enzyme-Linked Immunospot Assay | Herpes Zoster Vaccine - therapeutic use | Methotrexate - therapeutic use | Arthritis, Rheumatoid - drug therapy | Immunoglobulin G - immunology | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Antibodies, Viral - immunology | Female | T-Lymphocytes - immunology | Aged | Drug Therapy, Combination | Pyrroles - therapeutic use | Immunogenicity, Vaccine - immunology | Antirheumatic Agents - therapeutic use | Herpes Zoster Vaccine - immunology | Immunoglobulin G | Vaccination | Viruses | Leukocytes (mononuclear) | Lymphocytes T | Arthritis | Vaccines | Immunity | Randomization | Lymphocytes | Varicella | Peripheral blood mononuclear cells | Safety | Methotrexate | Active control | Age | Enzyme-linked immunosorbent assay | Immune system | Enzymes | Herpes zoster | Immune response | Enumeration | Immune response (cell-mediated) | Glycoprotein | Patients | Immune response (humoral) | Immunogenicity | Rheumatoid arthritis | Rheumatoid Arthritis
Journal Article